instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Splenic infarction'. | Patient with Down syndrome and relapsed acute lymphoblastic leukemia with sustained remission despite only partial R3 chemotherapy.
DS-ALL has a higher rate of relapse and treatment-related mortality. The newer immunotherapies are potentially better options. Relapsed ALL with positive MRD has a poor prognosis. Transien... | CYCLOPHOSPHAMIDE, CYTARABINE, DAUNORUBICIN HYDROCHLORIDE, DEXAMETHASONE, ETOPOSIDE, LEUCOVORIN CALCIUM, METHOTREXATE, MITOXANTRONE HYDROCHLORIDE, PEGASPARGASE, PREDNISONE, VINCRISTINE SULFATE | DrugsGivenReaction | CC BY | 33768794 | 19,542,515 | 2021-03 |
What was the administration route of drug 'CYTARABINE'? | Patient with Down syndrome and relapsed acute lymphoblastic leukemia with sustained remission despite only partial R3 chemotherapy.
DS-ALL has a higher rate of relapse and treatment-related mortality. The newer immunotherapies are potentially better options. Relapsed ALL with positive MRD has a poor prognosis. Transien... | Intrathecal | DrugAdministrationRoute | CC BY | 33768794 | 19,483,887 | 2021-03 |
What was the administration route of drug 'DAUNORUBICIN HYDROCHLORIDE'? | Patient with Down syndrome and relapsed acute lymphoblastic leukemia with sustained remission despite only partial R3 chemotherapy.
DS-ALL has a higher rate of relapse and treatment-related mortality. The newer immunotherapies are potentially better options. Relapsed ALL with positive MRD has a poor prognosis. Transien... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33768794 | 19,542,515 | 2021-03 |
What was the administration route of drug 'DAUNORUBICIN'? | Patient with Down syndrome and relapsed acute lymphoblastic leukemia with sustained remission despite only partial R3 chemotherapy.
DS-ALL has a higher rate of relapse and treatment-related mortality. The newer immunotherapies are potentially better options. Relapsed ALL with positive MRD has a poor prognosis. Transien... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33768794 | 19,483,887 | 2021-03 |
What was the administration route of drug 'LEUCOVORIN CALCIUM'? | Patient with Down syndrome and relapsed acute lymphoblastic leukemia with sustained remission despite only partial R3 chemotherapy.
DS-ALL has a higher rate of relapse and treatment-related mortality. The newer immunotherapies are potentially better options. Relapsed ALL with positive MRD has a poor prognosis. Transien... | Oral | DrugAdministrationRoute | CC BY | 33768794 | 19,542,515 | 2021-03 |
What was the administration route of drug 'METHOTREXATE SODIUM'? | Patient with Down syndrome and relapsed acute lymphoblastic leukemia with sustained remission despite only partial R3 chemotherapy.
DS-ALL has a higher rate of relapse and treatment-related mortality. The newer immunotherapies are potentially better options. Relapsed ALL with positive MRD has a poor prognosis. Transien... | Intrathecal | DrugAdministrationRoute | CC BY | 33768794 | 19,315,718 | 2021-03 |
What was the administration route of drug 'PEGASPARGASE'? | Patient with Down syndrome and relapsed acute lymphoblastic leukemia with sustained remission despite only partial R3 chemotherapy.
DS-ALL has a higher rate of relapse and treatment-related mortality. The newer immunotherapies are potentially better options. Relapsed ALL with positive MRD has a poor prognosis. Transien... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33768794 | 19,542,515 | 2021-03 |
What was the administration route of drug 'PREDNISONE'? | Patient with Down syndrome and relapsed acute lymphoblastic leukemia with sustained remission despite only partial R3 chemotherapy.
DS-ALL has a higher rate of relapse and treatment-related mortality. The newer immunotherapies are potentially better options. Relapsed ALL with positive MRD has a poor prognosis. Transien... | Oral | DrugAdministrationRoute | CC BY | 33768794 | 19,542,515 | 2021-03 |
What was the administration route of drug 'VINCRISTINE SULFATE'? | Patient with Down syndrome and relapsed acute lymphoblastic leukemia with sustained remission despite only partial R3 chemotherapy.
DS-ALL has a higher rate of relapse and treatment-related mortality. The newer immunotherapies are potentially better options. Relapsed ALL with positive MRD has a poor prognosis. Transien... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33768794 | 19,542,515 | 2021-03 |
What was the administration route of drug 'VINCRISTINE'? | Patient with Down syndrome and relapsed acute lymphoblastic leukemia with sustained remission despite only partial R3 chemotherapy.
DS-ALL has a higher rate of relapse and treatment-related mortality. The newer immunotherapies are potentially better options. Relapsed ALL with positive MRD has a poor prognosis. Transien... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33768794 | 19,483,887 | 2021-03 |
What was the dosage of drug 'ALLOPURINOL'? | Patient with Down syndrome and relapsed acute lymphoblastic leukemia with sustained remission despite only partial R3 chemotherapy.
DS-ALL has a higher rate of relapse and treatment-related mortality. The newer immunotherapies are potentially better options. Relapsed ALL with positive MRD has a poor prognosis. Transien... | 300 MILLIGRAM DAILY; CHILDREN^S ONCOLOGY GROUP (COG) STUDY AALL1131 PROTOCOL | DrugDosageText | CC BY | 33768794 | 19,483,887 | 2021-03 |
What was the dosage of drug 'DAUNORUBICIN HYDROCHLORIDE'? | Patient with Down syndrome and relapsed acute lymphoblastic leukemia with sustained remission despite only partial R3 chemotherapy.
DS-ALL has a higher rate of relapse and treatment-related mortality. The newer immunotherapies are potentially better options. Relapsed ALL with positive MRD has a poor prognosis. Transien... | 25 MG/M?, INDUCTION, DAYS 1, 8, 15, 22 | DrugDosageText | CC BY | 33768794 | 19,542,515 | 2021-03 |
What was the dosage of drug 'DAUNORUBICIN'? | Patient with Down syndrome and relapsed acute lymphoblastic leukemia with sustained remission despite only partial R3 chemotherapy.
DS-ALL has a higher rate of relapse and treatment-related mortality. The newer immunotherapies are potentially better options. Relapsed ALL with positive MRD has a poor prognosis. Transien... | RECEIVED ON DAY 1, 8, 15, AND 22; CHILDREN^S ONCOLOGY GROUP (COG) STUDY AALL1131 PROTOCOL | DrugDosageText | CC BY | 33768794 | 19,483,887 | 2021-03 |
What was the outcome of reaction 'Deep vein thrombosis'? | Patient with Down syndrome and relapsed acute lymphoblastic leukemia with sustained remission despite only partial R3 chemotherapy.
DS-ALL has a higher rate of relapse and treatment-related mortality. The newer immunotherapies are potentially better options. Relapsed ALL with positive MRD has a poor prognosis. Transien... | Recovered | ReactionOutcome | CC BY | 33768794 | 19,542,515 | 2021-03 |
What was the outcome of reaction 'Multiple organ dysfunction syndrome'? | Patient with Down syndrome and relapsed acute lymphoblastic leukemia with sustained remission despite only partial R3 chemotherapy.
DS-ALL has a higher rate of relapse and treatment-related mortality. The newer immunotherapies are potentially better options. Relapsed ALL with positive MRD has a poor prognosis. Transien... | Recovered | ReactionOutcome | CC BY | 33768794 | 19,542,515 | 2021-03 |
What was the outcome of reaction 'Splenic infarction'? | Patient with Down syndrome and relapsed acute lymphoblastic leukemia with sustained remission despite only partial R3 chemotherapy.
DS-ALL has a higher rate of relapse and treatment-related mortality. The newer immunotherapies are potentially better options. Relapsed ALL with positive MRD has a poor prognosis. Transien... | Not recovered | ReactionOutcome | CC BY | 33768794 | 19,542,515 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'PaO2/FiO2 ratio decreased'. | Use of a novel implantable cardioverter-defibrillator multisensor algorithm for heart failure monitoring in a COVID-19 patient: A case report.
We report the case of a patient implanted with an implantable defibrillator endowed with a multisensor algorithm for heart failure monitoring. Automatic measurement of multiple ... | HYDROXYCHLOROQUINE, LOPINAVIR\RITONAVIR | DrugsGivenReaction | CC BY-NC | 33768806 | 19,435,766 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Chest wall abscess'. | Significant elevation of free itraconazole concentration at onset of adverse effects: A case report.
Free itraconazole and hydroxyitraconazole concentrations were markedly elevated despite almost no changes in total concentrations when itraconazole was discontinued due to adverse effects. Elevated free itraconazole con... | AMPHOTERICIN B, CASPOFUNGIN, ITRACONAZOLE, VORICONAZOLE | DrugsGivenReaction | CC BY-NC-ND | 33768808 | 19,318,501 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Death'. | Significant elevation of free itraconazole concentration at onset of adverse effects: A case report.
Free itraconazole and hydroxyitraconazole concentrations were markedly elevated despite almost no changes in total concentrations when itraconazole was discontinued due to adverse effects. Elevated free itraconazole con... | AMPHOTERICIN B, CASPOFUNGIN, ITRACONAZOLE, VORICONAZOLE | DrugsGivenReaction | CC BY-NC-ND | 33768808 | 19,318,501 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug effect less than expected'. | Significant elevation of free itraconazole concentration at onset of adverse effects: A case report.
Free itraconazole and hydroxyitraconazole concentrations were markedly elevated despite almost no changes in total concentrations when itraconazole was discontinued due to adverse effects. Elevated free itraconazole con... | AMPHOTERICIN B, CASPOFUNGIN, ITRACONAZOLE, VORICONAZOLE | DrugsGivenReaction | CC BY-NC-ND | 33768808 | 19,318,501 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug resistance'. | Significant elevation of free itraconazole concentration at onset of adverse effects: A case report.
Free itraconazole and hydroxyitraconazole concentrations were markedly elevated despite almost no changes in total concentrations when itraconazole was discontinued due to adverse effects. Elevated free itraconazole con... | AMPHOTERICIN B, CASPOFUNGIN, ITRACONAZOLE, VORICONAZOLE | DrugsGivenReaction | CC BY-NC-ND | 33768808 | 19,318,501 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Fatigue'. | Significant elevation of free itraconazole concentration at onset of adverse effects: A case report.
Free itraconazole and hydroxyitraconazole concentrations were markedly elevated despite almost no changes in total concentrations when itraconazole was discontinued due to adverse effects. Elevated free itraconazole con... | AMPHOTERICIN B, CASPOFUNGIN, ITRACONAZOLE | DrugsGivenReaction | CC BY-NC-ND | 33768808 | 18,862,467 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatic function abnormal'. | Significant elevation of free itraconazole concentration at onset of adverse effects: A case report.
Free itraconazole and hydroxyitraconazole concentrations were markedly elevated despite almost no changes in total concentrations when itraconazole was discontinued due to adverse effects. Elevated free itraconazole con... | AMPHOTERICIN B, CASPOFUNGIN, ITRACONAZOLE | DrugsGivenReaction | CC BY-NC-ND | 33768808 | 18,862,467 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Subcutaneous abscess'. | Significant elevation of free itraconazole concentration at onset of adverse effects: A case report.
Free itraconazole and hydroxyitraconazole concentrations were markedly elevated despite almost no changes in total concentrations when itraconazole was discontinued due to adverse effects. Elevated free itraconazole con... | AMPHOTERICIN B, CASPOFUNGIN, ITRACONAZOLE, VORICONAZOLE | DrugsGivenReaction | CC BY-NC-ND | 33768808 | 19,318,501 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Toxicity to various agents'. | Significant elevation of free itraconazole concentration at onset of adverse effects: A case report.
Free itraconazole and hydroxyitraconazole concentrations were markedly elevated despite almost no changes in total concentrations when itraconazole was discontinued due to adverse effects. Elevated free itraconazole con... | AMPHOTERICIN B, CASPOFUNGIN, ITRACONAZOLE | DrugsGivenReaction | CC BY-NC-ND | 33768808 | 18,862,467 | 2021-03 |
What is the weight of the patient? | Significant elevation of free itraconazole concentration at onset of adverse effects: A case report.
Free itraconazole and hydroxyitraconazole concentrations were markedly elevated despite almost no changes in total concentrations when itraconazole was discontinued due to adverse effects. Elevated free itraconazole con... | 53.3 kg. | Weight | CC BY-NC-ND | 33768808 | 18,862,467 | 2021-03 |
What was the administration route of drug 'OXYGEN'? | Significant elevation of free itraconazole concentration at onset of adverse effects: A case report.
Free itraconazole and hydroxyitraconazole concentrations were markedly elevated despite almost no changes in total concentrations when itraconazole was discontinued due to adverse effects. Elevated free itraconazole con... | Respiratory (inhalation) | DrugAdministrationRoute | CC BY-NC-ND | 33768808 | 18,858,096 | 2021-03 |
What was the outcome of reaction 'Cardiac failure congestive'? | Significant elevation of free itraconazole concentration at onset of adverse effects: A case report.
Free itraconazole and hydroxyitraconazole concentrations were markedly elevated despite almost no changes in total concentrations when itraconazole was discontinued due to adverse effects. Elevated free itraconazole con... | Fatal | ReactionOutcome | CC BY-NC-ND | 33768808 | 18,858,096 | 2021-03 |
What was the outcome of reaction 'Death'? | Significant elevation of free itraconazole concentration at onset of adverse effects: A case report.
Free itraconazole and hydroxyitraconazole concentrations were markedly elevated despite almost no changes in total concentrations when itraconazole was discontinued due to adverse effects. Elevated free itraconazole con... | Fatal | ReactionOutcome | CC BY-NC-ND | 33768808 | 19,318,501 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Severe SARS-CoV-2 infection presenting with acute kidney injury and diabetic ketoacidosis complicated by pancreatitis in a 53-year man with hypertension.
Severe COVID-19 infection is associated with significant stress and marked immune response that can affect many organs and precipitate DKA, pancreatitis, and acute re... | ANIDULAFUNGIN, AZITHROMYCIN ANHYDROUS, CIPROFLOXACIN, HYDROXYCHLOROQUINE, MEROPENEM, METHYLPREDNISOLONE, TOCILIZUMAB, VANCOMYCIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33768811 | 19,432,223 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Severe SARS-CoV-2 infection presenting with acute kidney injury and diabetic ketoacidosis complicated by pancreatitis in a 53-year man with hypertension.
Severe COVID-19 infection is associated with significant stress and marked immune response that can affect many organs and precipitate DKA, pancreatitis, and acute re... | ANIDULAFUNGIN, AZITHROMYCIN ANHYDROUS, CIPROFLOXACIN, HYDROXYCHLOROQUINE, MEROPENEM, METHYLPREDNISOLONE, TOCILIZUMAB, VANCOMYCIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33768811 | 19,432,223 | 2021-03 |
What was the dosage of drug 'TOCILIZUMAB'? | Severe SARS-CoV-2 infection presenting with acute kidney injury and diabetic ketoacidosis complicated by pancreatitis in a 53-year man with hypertension.
Severe COVID-19 infection is associated with significant stress and marked immune response that can affect many organs and precipitate DKA, pancreatitis, and acute re... | UNK, DAILY | DrugDosageText | CC BY | 33768811 | 19,432,223 | 2021-03 |
What was the outcome of reaction 'Drug ineffective'? | Severe SARS-CoV-2 infection presenting with acute kidney injury and diabetic ketoacidosis complicated by pancreatitis in a 53-year man with hypertension.
Severe COVID-19 infection is associated with significant stress and marked immune response that can affect many organs and precipitate DKA, pancreatitis, and acute re... | Fatal | ReactionOutcome | CC BY | 33768811 | 19,432,223 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Areflexia'. | Hypokalemic paralysis in hyperthyroidism: Not all that glitter are gold.
Abnormal acid-base status (metabolic acidosis or alkalosis), inappropriate urine electrolytes excretion (high or low Na+ and Cl-), and higher required dose of potassium supplement (4-5 mmol/kg) are suggestive of non-TPP causes of hypokalemia.
1 IN... | CARBIMAZOLE, FUROSEMIDE | DrugsGivenReaction | CC BY-NC-ND | 33768827 | 19,378,026 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Atrioventricular block first degree'. | Hypokalemic paralysis in hyperthyroidism: Not all that glitter are gold.
Abnormal acid-base status (metabolic acidosis or alkalosis), inappropriate urine electrolytes excretion (high or low Na+ and Cl-), and higher required dose of potassium supplement (4-5 mmol/kg) are suggestive of non-TPP causes of hypokalemia.
1 IN... | CARBIMAZOLE, FUROSEMIDE | DrugsGivenReaction | CC BY-NC-ND | 33768827 | 19,378,026 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug abuse'. | Hypokalemic paralysis in hyperthyroidism: Not all that glitter are gold.
Abnormal acid-base status (metabolic acidosis or alkalosis), inappropriate urine electrolytes excretion (high or low Na+ and Cl-), and higher required dose of potassium supplement (4-5 mmol/kg) are suggestive of non-TPP causes of hypokalemia.
1 IN... | CARBIMAZOLE, FUROSEMIDE | DrugsGivenReaction | CC BY-NC-ND | 33768827 | 19,378,026 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Electrocardiogram U-wave prominent'. | Hypokalemic paralysis in hyperthyroidism: Not all that glitter are gold.
Abnormal acid-base status (metabolic acidosis or alkalosis), inappropriate urine electrolytes excretion (high or low Na+ and Cl-), and higher required dose of potassium supplement (4-5 mmol/kg) are suggestive of non-TPP causes of hypokalemia.
1 IN... | CARBIMAZOLE, FUROSEMIDE | DrugsGivenReaction | CC BY-NC-ND | 33768827 | 19,378,026 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Familial periodic paralysis'. | Hypokalemic paralysis in hyperthyroidism: Not all that glitter are gold.
Abnormal acid-base status (metabolic acidosis or alkalosis), inappropriate urine electrolytes excretion (high or low Na+ and Cl-), and higher required dose of potassium supplement (4-5 mmol/kg) are suggestive of non-TPP causes of hypokalemia.
1 IN... | CARBIMAZOLE, FUROSEMIDE | DrugsGivenReaction | CC BY-NC-ND | 33768827 | 19,378,026 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypochloraemia'. | Hypokalemic paralysis in hyperthyroidism: Not all that glitter are gold.
Abnormal acid-base status (metabolic acidosis or alkalosis), inappropriate urine electrolytes excretion (high or low Na+ and Cl-), and higher required dose of potassium supplement (4-5 mmol/kg) are suggestive of non-TPP causes of hypokalemia.
1 IN... | CARBIMAZOLE, FUROSEMIDE | DrugsGivenReaction | CC BY-NC-ND | 33768827 | 19,378,026 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypokalaemia'. | Hypokalemic paralysis in hyperthyroidism: Not all that glitter are gold.
Abnormal acid-base status (metabolic acidosis or alkalosis), inappropriate urine electrolytes excretion (high or low Na+ and Cl-), and higher required dose of potassium supplement (4-5 mmol/kg) are suggestive of non-TPP causes of hypokalemia.
1 IN... | CARBIMAZOLE, FUROSEMIDE | DrugsGivenReaction | CC BY-NC-ND | 33768827 | 19,378,026 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Metabolic alkalosis'. | Hypokalemic paralysis in hyperthyroidism: Not all that glitter are gold.
Abnormal acid-base status (metabolic acidosis or alkalosis), inappropriate urine electrolytes excretion (high or low Na+ and Cl-), and higher required dose of potassium supplement (4-5 mmol/kg) are suggestive of non-TPP causes of hypokalemia.
1 IN... | CARBIMAZOLE, FUROSEMIDE | DrugsGivenReaction | CC BY-NC-ND | 33768827 | 19,378,026 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Monoplegia'. | Hypokalemic paralysis in hyperthyroidism: Not all that glitter are gold.
Abnormal acid-base status (metabolic acidosis or alkalosis), inappropriate urine electrolytes excretion (high or low Na+ and Cl-), and higher required dose of potassium supplement (4-5 mmol/kg) are suggestive of non-TPP causes of hypokalemia.
1 IN... | CARBIMAZOLE, FUROSEMIDE | DrugsGivenReaction | CC BY-NC-ND | 33768827 | 19,378,026 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Thyrotoxic periodic paralysis'. | Hypokalemic paralysis in hyperthyroidism: Not all that glitter are gold.
Abnormal acid-base status (metabolic acidosis or alkalosis), inappropriate urine electrolytes excretion (high or low Na+ and Cl-), and higher required dose of potassium supplement (4-5 mmol/kg) are suggestive of non-TPP causes of hypokalemia.
1 IN... | CARBIMAZOLE, FUROSEMIDE | DrugsGivenReaction | CC BY-NC-ND | 33768827 | 19,378,026 | 2021-03 |
What was the dosage of drug 'CARBIMAZOLE'? | Hypokalemic paralysis in hyperthyroidism: Not all that glitter are gold.
Abnormal acid-base status (metabolic acidosis or alkalosis), inappropriate urine electrolytes excretion (high or low Na+ and Cl-), and higher required dose of potassium supplement (4-5 mmol/kg) are suggestive of non-TPP causes of hypokalemia.
1 IN... | 10 mg (milligrams). | DrugDosage | CC BY-NC-ND | 33768827 | 19,359,470 | 2021-03 |
What was the outcome of reaction 'Areflexia'? | Hypokalemic paralysis in hyperthyroidism: Not all that glitter are gold.
Abnormal acid-base status (metabolic acidosis or alkalosis), inappropriate urine electrolytes excretion (high or low Na+ and Cl-), and higher required dose of potassium supplement (4-5 mmol/kg) are suggestive of non-TPP causes of hypokalemia.
1 IN... | Recovered | ReactionOutcome | CC BY-NC-ND | 33768827 | 19,378,026 | 2021-03 |
What was the outcome of reaction 'Drug abuse'? | Hypokalemic paralysis in hyperthyroidism: Not all that glitter are gold.
Abnormal acid-base status (metabolic acidosis or alkalosis), inappropriate urine electrolytes excretion (high or low Na+ and Cl-), and higher required dose of potassium supplement (4-5 mmol/kg) are suggestive of non-TPP causes of hypokalemia.
1 IN... | Recovered | ReactionOutcome | CC BY-NC-ND | 33768827 | 19,378,026 | 2021-03 |
What was the outcome of reaction 'Familial periodic paralysis'? | Hypokalemic paralysis in hyperthyroidism: Not all that glitter are gold.
Abnormal acid-base status (metabolic acidosis or alkalosis), inappropriate urine electrolytes excretion (high or low Na+ and Cl-), and higher required dose of potassium supplement (4-5 mmol/kg) are suggestive of non-TPP causes of hypokalemia.
1 IN... | Recovered | ReactionOutcome | CC BY-NC-ND | 33768827 | 19,378,026 | 2021-03 |
What was the outcome of reaction 'Monoplegia'? | Hypokalemic paralysis in hyperthyroidism: Not all that glitter are gold.
Abnormal acid-base status (metabolic acidosis or alkalosis), inappropriate urine electrolytes excretion (high or low Na+ and Cl-), and higher required dose of potassium supplement (4-5 mmol/kg) are suggestive of non-TPP causes of hypokalemia.
1 IN... | Recovered | ReactionOutcome | CC BY-NC-ND | 33768827 | 19,378,026 | 2021-03 |
What was the outcome of reaction 'Thyrotoxic periodic paralysis'? | Hypokalemic paralysis in hyperthyroidism: Not all that glitter are gold.
Abnormal acid-base status (metabolic acidosis or alkalosis), inappropriate urine electrolytes excretion (high or low Na+ and Cl-), and higher required dose of potassium supplement (4-5 mmol/kg) are suggestive of non-TPP causes of hypokalemia.
1 IN... | Recovered | ReactionOutcome | CC BY-NC-ND | 33768827 | 19,378,026 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Very severe aplastic anemia in an 80-year-old man.
Although the patient with very severe aplastic anemia might be a fit elderly receiving standard therapy, there are factors which contribute to an adverse outcome such as severity of pancytopenia, absence of minor paroxysmal nocturnal hemoglobinuria clone and infective ... | ACYCLOVIR, CYCLOSPORINE, ELTROMBOPAG, EQUINE THYMOCYTE IMMUNE GLOBULIN, FLUCONAZOLE, METHYLPREDNISOLONE, SULFAMETHOXAZOLE\TRIMETHOPRIM | DrugsGivenReaction | CC BY-NC-ND | 33768838 | 19,450,765 | 2021-03 |
What is the weight of the patient? | Very severe aplastic anemia in an 80-year-old man.
Although the patient with very severe aplastic anemia might be a fit elderly receiving standard therapy, there are factors which contribute to an adverse outcome such as severity of pancytopenia, absence of minor paroxysmal nocturnal hemoglobinuria clone and infective ... | 75 kg. | Weight | CC BY-NC-ND | 33768838 | 19,466,547 | 2021-03 |
What was the administration route of drug 'CYCLOSPORINE'? | Very severe aplastic anemia in an 80-year-old man.
Although the patient with very severe aplastic anemia might be a fit elderly receiving standard therapy, there are factors which contribute to an adverse outcome such as severity of pancytopenia, absence of minor paroxysmal nocturnal hemoglobinuria clone and infective ... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33768838 | 19,458,972 | 2021-03 |
What was the administration route of drug 'ELTROMBOPAG OLAMINE'? | Very severe aplastic anemia in an 80-year-old man.
Although the patient with very severe aplastic anemia might be a fit elderly receiving standard therapy, there are factors which contribute to an adverse outcome such as severity of pancytopenia, absence of minor paroxysmal nocturnal hemoglobinuria clone and infective ... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33768838 | 19,458,972 | 2021-03 |
What was the administration route of drug 'ELTROMBOPAG'? | Very severe aplastic anemia in an 80-year-old man.
Although the patient with very severe aplastic anemia might be a fit elderly receiving standard therapy, there are factors which contribute to an adverse outcome such as severity of pancytopenia, absence of minor paroxysmal nocturnal hemoglobinuria clone and infective ... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33768838 | 19,450,765 | 2021-03 |
What was the administration route of drug 'GRANULOCYTE COLONY-STIMULATING FACTOR NOS'? | Very severe aplastic anemia in an 80-year-old man.
Although the patient with very severe aplastic anemia might be a fit elderly receiving standard therapy, there are factors which contribute to an adverse outcome such as severity of pancytopenia, absence of minor paroxysmal nocturnal hemoglobinuria clone and infective ... | Subcutaneous | DrugAdministrationRoute | CC BY-NC-ND | 33768838 | 19,458,972 | 2021-03 |
What was the administration route of drug 'METHYLPREDNISOLONE'? | Very severe aplastic anemia in an 80-year-old man.
Although the patient with very severe aplastic anemia might be a fit elderly receiving standard therapy, there are factors which contribute to an adverse outcome such as severity of pancytopenia, absence of minor paroxysmal nocturnal hemoglobinuria clone and infective ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 33768838 | 19,458,972 | 2021-03 |
What was the administration route of drug 'THYMOCYTE IMMUNE GLOBULIN NOS'? | Very severe aplastic anemia in an 80-year-old man.
Although the patient with very severe aplastic anemia might be a fit elderly receiving standard therapy, there are factors which contribute to an adverse outcome such as severity of pancytopenia, absence of minor paroxysmal nocturnal hemoglobinuria clone and infective ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 33768838 | 19,458,972 | 2021-03 |
What was the dosage of drug 'ELTROMBOPAG'? | Very severe aplastic anemia in an 80-year-old man.
Although the patient with very severe aplastic anemia might be a fit elderly receiving standard therapy, there are factors which contribute to an adverse outcome such as severity of pancytopenia, absence of minor paroxysmal nocturnal hemoglobinuria clone and infective ... | 50 MG, QD | DrugDosageText | CC BY-NC-ND | 33768838 | 19,450,765 | 2021-03 |
What was the dosage of drug 'EQUINE THYMOCYTE IMMUNE GLOBULIN'? | Very severe aplastic anemia in an 80-year-old man.
Although the patient with very severe aplastic anemia might be a fit elderly receiving standard therapy, there are factors which contribute to an adverse outcome such as severity of pancytopenia, absence of minor paroxysmal nocturnal hemoglobinuria clone and infective ... | 40 MG/KG FOR 4 DAYS | DrugDosageText | CC BY-NC-ND | 33768838 | 19,450,765 | 2021-03 |
What was the dosage of drug 'METHYLPREDNISOLONE'? | Very severe aplastic anemia in an 80-year-old man.
Although the patient with very severe aplastic anemia might be a fit elderly receiving standard therapy, there are factors which contribute to an adverse outcome such as severity of pancytopenia, absence of minor paroxysmal nocturnal hemoglobinuria clone and infective ... | 1 MG/KG (30 MINUTES BEFORE AND AFTER THE ATGAM) | DrugDosageText | CC BY-NC-ND | 33768838 | 19,450,765 | 2021-03 |
What was the outcome of reaction 'Pneumonia'? | Very severe aplastic anemia in an 80-year-old man.
Although the patient with very severe aplastic anemia might be a fit elderly receiving standard therapy, there are factors which contribute to an adverse outcome such as severity of pancytopenia, absence of minor paroxysmal nocturnal hemoglobinuria clone and infective ... | Fatal | ReactionOutcome | CC BY-NC-ND | 33768838 | 19,466,547 | 2021-03 |
What was the outcome of reaction 'Sepsis'? | Very severe aplastic anemia in an 80-year-old man.
Although the patient with very severe aplastic anemia might be a fit elderly receiving standard therapy, there are factors which contribute to an adverse outcome such as severity of pancytopenia, absence of minor paroxysmal nocturnal hemoglobinuria clone and infective ... | Fatal | ReactionOutcome | CC BY-NC-ND | 33768838 | 19,466,547 | 2021-03 |
What was the administration route of drug 'BOSUTINIB MONOHYDRATE'? | High-grade B-cell lymphoma developed during the treatment of chronic myeloid leukemia with bosutinib.
Tyrosine kinase inhibitor (TKI) can help to increase the survival time in chronic myeloid leukemia (CML) patients; however, the risk of secondary malignancies due to TKIs is a growing concern. Only few reports showed c... | Oral | DrugAdministrationRoute | CC BY | 33768841 | 18,800,070 | 2021-03 |
What was the dosage of drug 'BOSUTINIB MONOHYDRATE'? | High-grade B-cell lymphoma developed during the treatment of chronic myeloid leukemia with bosutinib.
Tyrosine kinase inhibitor (TKI) can help to increase the survival time in chronic myeloid leukemia (CML) patients; however, the risk of secondary malignancies due to TKIs is a growing concern. Only few reports showed c... | 400?500 MG, ONCE DAILY | DrugDosageText | CC BY | 33768841 | 18,800,070 | 2021-03 |
What was the dosage of drug 'BOSUTINIB'? | High-grade B-cell lymphoma developed during the treatment of chronic myeloid leukemia with bosutinib.
Tyrosine kinase inhibitor (TKI) can help to increase the survival time in chronic myeloid leukemia (CML) patients; however, the risk of secondary malignancies due to TKIs is a growing concern. Only few reports showed c... | DOSE: 400?500 MG/DAY | DrugDosageText | CC BY | 33768841 | 19,318,571 | 2021-03 |
What was the outcome of reaction 'High-grade B-cell lymphoma'? | High-grade B-cell lymphoma developed during the treatment of chronic myeloid leukemia with bosutinib.
Tyrosine kinase inhibitor (TKI) can help to increase the survival time in chronic myeloid leukemia (CML) patients; however, the risk of secondary malignancies due to TKIs is a growing concern. Only few reports showed c... | Recovered | ReactionOutcome | CC BY | 33768841 | 18,800,070 | 2021-03 |
What was the outcome of reaction 'Second primary malignancy'? | High-grade B-cell lymphoma developed during the treatment of chronic myeloid leukemia with bosutinib.
Tyrosine kinase inhibitor (TKI) can help to increase the survival time in chronic myeloid leukemia (CML) patients; however, the risk of secondary malignancies due to TKIs is a growing concern. Only few reports showed c... | Recovered | ReactionOutcome | CC BY | 33768841 | 18,800,070 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Fatigue'. | Prolonged encephalopathy and associated nonconvulsive seizures from suspected pregabalin and tapentadol: Two case reports and review of literature.
A combination of pregabalin and tapentadol may be associated with prolonged encephalopathy.
1 INTRODUCTION
Chronic pain may sometimes require treatment with combination of... | AMILORIDE HYDROCHLORIDE\HYDROCHLOROTHIAZIDE, AMITRIPTYLINE, ASPIRIN, DULOXETINE, FUROSEMIDE, PREGABALIN, PROPRANOLOL HYDROCHLORIDE, TAPENTADOL | DrugsGivenReaction | CC BY-NC-ND | 33768845 | 19,356,005 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Social avoidant behaviour'. | Prolonged encephalopathy and associated nonconvulsive seizures from suspected pregabalin and tapentadol: Two case reports and review of literature.
A combination of pregabalin and tapentadol may be associated with prolonged encephalopathy.
1 INTRODUCTION
Chronic pain may sometimes require treatment with combination of... | INSULIN NOS, PAROXETINE, PREGABALIN, TAPENTADOL | DrugsGivenReaction | CC BY-NC-ND | 33768845 | 19,355,040 | 2021-03 |
What was the administration route of drug 'PREGABALIN'? | Prolonged encephalopathy and associated nonconvulsive seizures from suspected pregabalin and tapentadol: Two case reports and review of literature.
A combination of pregabalin and tapentadol may be associated with prolonged encephalopathy.
1 INTRODUCTION
Chronic pain may sometimes require treatment with combination of... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33768845 | 18,936,944 | 2021-03 |
What was the dosage of drug 'AMILORIDE HYDROCHLORIDE\HYDROCHLOROTHIAZIDE'? | Prolonged encephalopathy and associated nonconvulsive seizures from suspected pregabalin and tapentadol: Two case reports and review of literature.
A combination of pregabalin and tapentadol may be associated with prolonged encephalopathy.
1 INTRODUCTION
Chronic pain may sometimes require treatment with combination of... | UNK (5/12.5 MG, DAILY) | DrugDosageText | CC BY-NC-ND | 33768845 | 18,940,951 | 2021-03 |
What was the outcome of reaction 'Agitation'? | Prolonged encephalopathy and associated nonconvulsive seizures from suspected pregabalin and tapentadol: Two case reports and review of literature.
A combination of pregabalin and tapentadol may be associated with prolonged encephalopathy.
1 INTRODUCTION
Chronic pain may sometimes require treatment with combination of... | Recovered | ReactionOutcome | CC BY-NC-ND | 33768845 | 19,355,040 | 2021-03 |
What was the outcome of reaction 'Encephalopathy'? | Prolonged encephalopathy and associated nonconvulsive seizures from suspected pregabalin and tapentadol: Two case reports and review of literature.
A combination of pregabalin and tapentadol may be associated with prolonged encephalopathy.
1 INTRODUCTION
Chronic pain may sometimes require treatment with combination of... | Recovered | ReactionOutcome | CC BY-NC-ND | 33768845 | 18,936,944 | 2021-03 |
What was the outcome of reaction 'Fatigue'? | Prolonged encephalopathy and associated nonconvulsive seizures from suspected pregabalin and tapentadol: Two case reports and review of literature.
A combination of pregabalin and tapentadol may be associated with prolonged encephalopathy.
1 INTRODUCTION
Chronic pain may sometimes require treatment with combination of... | Recovered | ReactionOutcome | CC BY-NC-ND | 33768845 | 19,356,005 | 2021-03 |
What was the outcome of reaction 'Generalised onset non-motor seizure'? | Prolonged encephalopathy and associated nonconvulsive seizures from suspected pregabalin and tapentadol: Two case reports and review of literature.
A combination of pregabalin and tapentadol may be associated with prolonged encephalopathy.
1 INTRODUCTION
Chronic pain may sometimes require treatment with combination of... | Recovered | ReactionOutcome | CC BY-NC-ND | 33768845 | 18,936,944 | 2021-03 |
What was the outcome of reaction 'Seizure'? | Prolonged encephalopathy and associated nonconvulsive seizures from suspected pregabalin and tapentadol: Two case reports and review of literature.
A combination of pregabalin and tapentadol may be associated with prolonged encephalopathy.
1 INTRODUCTION
Chronic pain may sometimes require treatment with combination of... | Recovered | ReactionOutcome | CC BY-NC-ND | 33768845 | 19,355,040 | 2021-03 |
What was the outcome of reaction 'Social avoidant behaviour'? | Prolonged encephalopathy and associated nonconvulsive seizures from suspected pregabalin and tapentadol: Two case reports and review of literature.
A combination of pregabalin and tapentadol may be associated with prolonged encephalopathy.
1 INTRODUCTION
Chronic pain may sometimes require treatment with combination of... | Recovered | ReactionOutcome | CC BY-NC-ND | 33768845 | 19,355,040 | 2021-03 |
What was the outcome of reaction 'Somnolence'? | Prolonged encephalopathy and associated nonconvulsive seizures from suspected pregabalin and tapentadol: Two case reports and review of literature.
A combination of pregabalin and tapentadol may be associated with prolonged encephalopathy.
1 INTRODUCTION
Chronic pain may sometimes require treatment with combination of... | Recovered | ReactionOutcome | CC BY-NC-ND | 33768845 | 19,355,040 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Blood lactate dehydrogenase increased'. | Disseminated carcinomatosis of the bone marrow from rectal cancer: A case report.
A 66-year-old man presented with worsening dyspnea. A colonoscopy revealed an elevated lesion at the rectosigmoid junction. The biopsy specimen and bone marrow aspiration demonstrated adenocarcinoma, leading to a diagnosis of disseminated... | FLUOROURACIL, LEUCOVORIN, OXALIPLATIN, PANITUMUMAB, PEGFILGRASTIM | DrugsGivenReaction | CC BY-NC-ND | 33768873 | 19,644,749 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Condition aggravated'. | Disseminated carcinomatosis of the bone marrow from rectal cancer: A case report.
A 66-year-old man presented with worsening dyspnea. A colonoscopy revealed an elevated lesion at the rectosigmoid junction. The biopsy specimen and bone marrow aspiration demonstrated adenocarcinoma, leading to a diagnosis of disseminated... | FLUOROURACIL, LEUCOVORIN, OXALIPLATIN, PANITUMUMAB, PEGFILGRASTIM | DrugsGivenReaction | CC BY-NC-ND | 33768873 | 19,644,749 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Decreased appetite'. | Disseminated carcinomatosis of the bone marrow from rectal cancer: A case report.
A 66-year-old man presented with worsening dyspnea. A colonoscopy revealed an elevated lesion at the rectosigmoid junction. The biopsy specimen and bone marrow aspiration demonstrated adenocarcinoma, leading to a diagnosis of disseminated... | FLUOROURACIL, LEUCOVORIN, OXALIPLATIN, PANITUMUMAB, PEGFILGRASTIM, THROMBOMODULIN ALFA | DrugsGivenReaction | CC BY-NC-ND | 33768873 | 19,685,805 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Disseminated carcinomatosis of the bone marrow from rectal cancer: A case report.
A 66-year-old man presented with worsening dyspnea. A colonoscopy revealed an elevated lesion at the rectosigmoid junction. The biopsy specimen and bone marrow aspiration demonstrated adenocarcinoma, leading to a diagnosis of disseminated... | FLUOROURACIL, LEUCOVORIN, OXALIPLATIN, PANITUMUMAB, PEGFILGRASTIM | DrugsGivenReaction | CC BY-NC-ND | 33768873 | 19,644,749 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Fatigue'. | Disseminated carcinomatosis of the bone marrow from rectal cancer: A case report.
A 66-year-old man presented with worsening dyspnea. A colonoscopy revealed an elevated lesion at the rectosigmoid junction. The biopsy specimen and bone marrow aspiration demonstrated adenocarcinoma, leading to a diagnosis of disseminated... | FLUOROURACIL, LEUCOVORIN, OXALIPLATIN, PANITUMUMAB, PEGFILGRASTIM, THROMBOMODULIN ALFA | DrugsGivenReaction | CC BY-NC-ND | 33768873 | 19,685,805 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypoaesthesia'. | Disseminated carcinomatosis of the bone marrow from rectal cancer: A case report.
A 66-year-old man presented with worsening dyspnea. A colonoscopy revealed an elevated lesion at the rectosigmoid junction. The biopsy specimen and bone marrow aspiration demonstrated adenocarcinoma, leading to a diagnosis of disseminated... | FLUOROURACIL, LEUCOVORIN, OXALIPLATIN, PANITUMUMAB, PEGFILGRASTIM | DrugsGivenReaction | CC BY-NC-ND | 33768873 | 19,644,749 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Multiple organ dysfunction syndrome'. | Disseminated carcinomatosis of the bone marrow from rectal cancer: A case report.
A 66-year-old man presented with worsening dyspnea. A colonoscopy revealed an elevated lesion at the rectosigmoid junction. The biopsy specimen and bone marrow aspiration demonstrated adenocarcinoma, leading to a diagnosis of disseminated... | FLUOROURACIL, LEUCOVORIN, OXALIPLATIN, PANITUMUMAB, PEGFILGRASTIM | DrugsGivenReaction | CC BY-NC-ND | 33768873 | 19,644,749 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pyrexia'. | Disseminated carcinomatosis of the bone marrow from rectal cancer: A case report.
A 66-year-old man presented with worsening dyspnea. A colonoscopy revealed an elevated lesion at the rectosigmoid junction. The biopsy specimen and bone marrow aspiration demonstrated adenocarcinoma, leading to a diagnosis of disseminated... | FLUOROURACIL, LEUCOVORIN, OXALIPLATIN, PANITUMUMAB, PEGFILGRASTIM, THROMBOMODULIN ALFA | DrugsGivenReaction | CC BY-NC-ND | 33768873 | 19,685,805 | 2021-03 |
What was the dosage of drug 'LEUCOVORIN CALCIUM'? | Disseminated carcinomatosis of the bone marrow from rectal cancer: A case report.
A 66-year-old man presented with worsening dyspnea. A colonoscopy revealed an elevated lesion at the rectosigmoid junction. The biopsy specimen and bone marrow aspiration demonstrated adenocarcinoma, leading to a diagnosis of disseminated... | UNK, CYCLIC (MFOLFOX6 THERAPY) | DrugDosageText | CC BY-NC-ND | 33768873 | 19,457,023 | 2021-03 |
What was the dosage of drug 'LEUCOVORIN'? | Disseminated carcinomatosis of the bone marrow from rectal cancer: A case report.
A 66-year-old man presented with worsening dyspnea. A colonoscopy revealed an elevated lesion at the rectosigmoid junction. The biopsy specimen and bone marrow aspiration demonstrated adenocarcinoma, leading to a diagnosis of disseminated... | AS PER THE MFOLFOX6 | DrugDosageText | CC BY-NC-ND | 33768873 | 19,685,805 | 2021-03 |
What was the outcome of reaction 'Disease progression'? | Disseminated carcinomatosis of the bone marrow from rectal cancer: A case report.
A 66-year-old man presented with worsening dyspnea. A colonoscopy revealed an elevated lesion at the rectosigmoid junction. The biopsy specimen and bone marrow aspiration demonstrated adenocarcinoma, leading to a diagnosis of disseminated... | Fatal | ReactionOutcome | CC BY-NC-ND | 33768873 | 19,644,749 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ruptured ectopic pregnancy'. | Case of rupture ectopic pregnancy with emergency contraception levonorgestrel 0.075 mg in a lactating woman.
Levonorgestrel emergency contraception (LNG-EC) tends to make uterus unfavorable for implantation but does not prevent embryo implantation. Emergency contraceptives pills should be used with caution among lactat... | LEVONORGESTREL | DrugsGivenReaction | CC BY-NC-ND | 33768899 | 19,142,159 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Achromobacter infection'. | Fatal temozolomide induced aplastic anemia in a female with Glioblastoma multiforme : A case report and literature review.
When seeing patients on Temozolomide with pancytopenia, aplastic anemia secondary to the drug should be considered early in the differentials to avoid permanent hematological suppression.
1 INTRODU... | FILGRASTIM, TEMOZOLOMIDE | DrugsGivenReaction | CC BY | 33768906 | 19,307,386 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Aspergillus infection'. | Fatal temozolomide induced aplastic anemia in a female with Glioblastoma multiforme : A case report and literature review.
When seeing patients on Temozolomide with pancytopenia, aplastic anemia secondary to the drug should be considered early in the differentials to avoid permanent hematological suppression.
1 INTRODU... | FILGRASTIM, TEMOZOLOMIDE | DrugsGivenReaction | CC BY | 33768906 | 19,307,386 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Bacteraemia'. | Fatal temozolomide induced aplastic anemia in a female with Glioblastoma multiforme : A case report and literature review.
When seeing patients on Temozolomide with pancytopenia, aplastic anemia secondary to the drug should be considered early in the differentials to avoid permanent hematological suppression.
1 INTRODU... | ENOXAPARIN, LEVETIRACETAM, TEMOZOLOMIDE | DrugsGivenReaction | CC BY | 33768906 | 19,113,031 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Bone marrow failure'. | Fatal temozolomide induced aplastic anemia in a female with Glioblastoma multiforme : A case report and literature review.
When seeing patients on Temozolomide with pancytopenia, aplastic anemia secondary to the drug should be considered early in the differentials to avoid permanent hematological suppression.
1 INTRODU... | FILGRASTIM, TEMOZOLOMIDE | DrugsGivenReaction | CC BY | 33768906 | 19,307,386 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cellulitis'. | Fatal temozolomide induced aplastic anemia in a female with Glioblastoma multiforme : A case report and literature review.
When seeing patients on Temozolomide with pancytopenia, aplastic anemia secondary to the drug should be considered early in the differentials to avoid permanent hematological suppression.
1 INTRODU... | FILGRASTIM, TEMOZOLOMIDE | DrugsGivenReaction | CC BY | 33768906 | 19,307,386 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Confusional state'. | Fatal temozolomide induced aplastic anemia in a female with Glioblastoma multiforme : A case report and literature review.
When seeing patients on Temozolomide with pancytopenia, aplastic anemia secondary to the drug should be considered early in the differentials to avoid permanent hematological suppression.
1 INTRODU... | FILGRASTIM, TEMOZOLOMIDE | DrugsGivenReaction | CC BY | 33768906 | 19,307,386 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective for unapproved indication'. | Fatal temozolomide induced aplastic anemia in a female with Glioblastoma multiforme : A case report and literature review.
When seeing patients on Temozolomide with pancytopenia, aplastic anemia secondary to the drug should be considered early in the differentials to avoid permanent hematological suppression.
1 INTRODU... | FILGRASTIM, TEMOZOLOMIDE | DrugsGivenReaction | CC BY | 33768906 | 19,307,386 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Enterococcal bacteraemia'. | Fatal temozolomide induced aplastic anemia in a female with Glioblastoma multiforme : A case report and literature review.
When seeing patients on Temozolomide with pancytopenia, aplastic anemia secondary to the drug should be considered early in the differentials to avoid permanent hematological suppression.
1 INTRODU... | FILGRASTIM, TEMOZOLOMIDE | DrugsGivenReaction | CC BY | 33768906 | 19,307,386 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Febrile neutropenia'. | Fatal temozolomide induced aplastic anemia in a female with Glioblastoma multiforme : A case report and literature review.
When seeing patients on Temozolomide with pancytopenia, aplastic anemia secondary to the drug should be considered early in the differentials to avoid permanent hematological suppression.
1 INTRODU... | FILGRASTIM, TEMOZOLOMIDE | DrugsGivenReaction | CC BY | 33768906 | 19,307,386 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypotension'. | Fatal temozolomide induced aplastic anemia in a female with Glioblastoma multiforme : A case report and literature review.
When seeing patients on Temozolomide with pancytopenia, aplastic anemia secondary to the drug should be considered early in the differentials to avoid permanent hematological suppression.
1 INTRODU... | FILGRASTIM, TEMOZOLOMIDE | DrugsGivenReaction | CC BY | 33768906 | 19,307,386 | 2021-03 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.